Predicta Biosciences
Boston, MA
Predicta Biosciences is a precision oncology firm that integrates multiomics and liquid biopsies to create diagnostic tools and therapies. They also have an in-house pipeline for novel immunotherapy targets in pre-clinical stages.
predictabiosciences.comCompany Details
Founded
- 2023
Employees
- Between 5 - 10 employees
Raised
- $28,600,000
Headquarters Location
- Boston, MA
Public
- No
Acquired
- No
CEO
- Kate Caves
Founders
- Kenneth C. AndersonIrene GhobrialGad GetzKeith FlahertyRomanos Sklavenitis-Pistofidis
Company Collections
These are collections Predicta Biosciences is a part of. Click on the collection name to view similar companies.
Predicta Biosciences' Industries
Predicta Biosciences Headquarters Location
Boston, MA 02110
Total Amount Raised: $28,600,000
Predicta Biosciences Funding Rounds
Series A
$23,400,000
Series A Investors
Engine VenturesBrightEdge - American Cancer SocietyLightchain CapitalMass General Brigham VenturesIllumina VenturesMyeloma Solutions FundCHEER for Dana-FaberSeed
$5,200,000
Seed Investors
Engine VenturesTime PartnersIllumina VenturesBrightEdge - American Cancer Society
Funding info provided by Diffbot.
Predicta Biosciences Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Predicta Biosciences.